229 related articles for article (PubMed ID: 19861681)
1. Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms.
Duckers C; Simioni P; Spiezia L; Radu C; Dabrilli P; Gavasso S; Rosing J; Castoldi E
Blood; 2010 Jan; 115(4):879-86. PubMed ID: 19861681
[TBL] [Abstract][Full Text] [Related]
2. Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency.
Duckers C; Simioni P; Spiezia L; Radu C; Gavasso S; Rosing J; Castoldi E
Blood; 2008 Nov; 112(9):3615-23. PubMed ID: 18695002
[TBL] [Abstract][Full Text] [Related]
3. Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma.
Castoldi E; Duckers C; Radu C; Spiezia L; Rossetto V; Tagariello G; Rosing J; Simioni P
J Thromb Haemost; 2011 May; 9(5):959-68. PubMed ID: 21320286
[TBL] [Abstract][Full Text] [Related]
4. Thrombin generation abnormalities in Quebec platelet disorder.
Brunet JG; Sharma T; Tasneem S; Liang M; Wilson MD; Rivard GE; Hayward CPM
Int J Lab Hematol; 2020 Dec; 42(6):801-809. PubMed ID: 32761872
[TBL] [Abstract][Full Text] [Related]
5. Advances in understanding the bleeding diathesis in factor V deficiency.
Duckers C; Simioni P; Rosing J; Castoldi E
Br J Haematol; 2009 Jun; 146(1):17-26. PubMed ID: 19438479
[TBL] [Abstract][Full Text] [Related]
6. Platelets and platelet-derived factor Va confer hemostatic competence in complete factor V deficiency.
Bouchard BA; Chapin J; Brummel-Ziedins KE; Durda P; Key NS; Tracy PB
Blood; 2015 Jun; 125(23):3647-50. PubMed ID: 25896652
[TBL] [Abstract][Full Text] [Related]
7. Parahemophilia: new insights into factor v deficiency.
Thalji N; Camire RM
Semin Thromb Hemost; 2013 Sep; 39(6):607-12. PubMed ID: 23893775
[TBL] [Abstract][Full Text] [Related]
8. Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII.
Shao Y; Wu W; Xu G; Wang X; Ding Q
Blood; 2019 Nov; 134(20):1745-1754. PubMed ID: 31558466
[TBL] [Abstract][Full Text] [Related]
9. Whole blood rotation thromboelastometry (ROTEM(®)) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V.
Spiezia L; Radu C; Campello E; Bulato C; Bertini D; Barillari G; De Angelis V; Pradella P; Zanon E; Simioni P
Haemophilia; 2012 May; 18(3):463-8. PubMed ID: 22176523
[TBL] [Abstract][Full Text] [Related]
10. "In vitro" correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate.
Bulato C; Novembrino C; Anzoletti MB; Spiezia L; Gavasso S; Berbenni C; Tagariello G; Farina C; Nardini I; Campello E; Peyvandi F; Simioni P
Haemophilia; 2018 Jul; 24(4):648-656. PubMed ID: 29578313
[TBL] [Abstract][Full Text] [Related]
11. Thrombin generation abnormalities in commonly encountered platelet function disorders.
Sharma T; Brunet JG; Tasneem S; Smith SA; Morrissey JH; Hayward CPM
Int J Lab Hematol; 2021 Dec; 43(6):1557-1565. PubMed ID: 34185390
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet-surface-bound proteins during coagulation under flow I: TFPI.
Miyazawa K; Fogelson AL; Leiderman K
Biophys J; 2023 Jan; 122(1):99-113. PubMed ID: 36403087
[TBL] [Abstract][Full Text] [Related]
13. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
[TBL] [Abstract][Full Text] [Related]
14. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va.
Gould WR; Silveira JR; Tracy PB
J Biol Chem; 2004 Jan; 279(4):2383-93. PubMed ID: 14594814
[TBL] [Abstract][Full Text] [Related]
15. Proteolysis of plasma-derived factor V following its endocytosis by megakaryocytes forms the platelet-derived factor V/Va pool.
Ayombil F; Abdalla S; Tracy PB; Bouchard BA
J Thromb Haemost; 2013 Aug; 11(8):1532-9. PubMed ID: 23710903
[TBL] [Abstract][Full Text] [Related]
16. Human platelet factor V is crosslinked to actin by FXIIIa during platelet activation by thrombin.
Wang DL; Annamalai AE; Ghosh S; Gewirtz AM; Colman RW
Thromb Res; 1990 Jan; 57(1):39-57. PubMed ID: 2300924
[TBL] [Abstract][Full Text] [Related]
17. Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.
Miletich JP; Majerus DW; Majerus PW
J Clin Invest; 1978 Oct; 62(4):824-31. PubMed ID: 701480
[TBL] [Abstract][Full Text] [Related]
18. Factor V deficiency: a concise review.
Huang JN; Koerper MA
Haemophilia; 2008 Nov; 14(6):1164-9. PubMed ID: 19141156
[TBL] [Abstract][Full Text] [Related]
19. Severe thrombophilia in a factor V-deficient patient homozygous for the Ala2086Asp mutation (FV Besançon).
Castoldi E; Hézard N; Mourey G; Wichapong K; Poggi M; Ibrahim-Kosta M; Thomassen MCLGD; Fournel A; Hayward CPM; Alessi MC; Hackeng TM; Rosing J; Morange PE
J Thromb Haemost; 2021 May; 19(5):1186-1199. PubMed ID: 33605529
[TBL] [Abstract][Full Text] [Related]
20. Platelets contain tissue factor pathway inhibitor-2 derived from megakaryocytes and inhibits fibrinolysis.
Vadivel K; Ponnuraj SM; Kumar Y; Zaiss AK; Bunce MW; Camire RM; Wu L; Evseenko D; Herschman HR; Bajaj MS; Bajaj SP
J Biol Chem; 2014 Nov; 289(45):31647-61. PubMed ID: 25262870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
